Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
Byung-Wan Lee (Lee BW), Yong-ho Lee (Lee Yh), Cheol-Young Park (Park CY), Eun-Jung Rhee (Rhee EJ), Won-Young Lee (Lee WY), Nan-Hee Kim (Kim NH), Kyung Mook Choi (Choi KM), Keun-Gyu Park (Park KG), Yeon-Kyung Choi (Choi YK), Bong-Soo Cha (Cha BS), Dae Ho Lee (Lee DH),
Diabetes Metab J. 2020;44(3):382-401.   Published online 2020 May 11     DOI: https://doi.org/10.4093/dmj.2020.0010
Citations to this article as recorded by Crossref logo
Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
Jaehyun Bae, Young Jun Won, Byung-Wan Lee
Life.2021; 11(3): 224.     CrossRef
Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment
Sook Jung Lee, Byung-Wan Lee
The Journal of Korean Diabetes.2021; 22(1): 38.     CrossRef
Non-alcoholic fatty liver disease
Elizabeth E Powell, Vincent Wai-Sun Wong, Mary Rinella
The Lancet.2021; 397(10290): 2212.     CrossRef
Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway
In-Jin Cho, Da-Hee Oh, Jin Yoo, You-Cheol Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, Soung Won Jeong, Ju-Young Moon, Sang-Ho Lee, Sung-Jig Lim, In-Kyung Jeong
Scientific Reports.2021;[Epub]     CrossRef
Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2021; 31(2): 14.     CrossRef
Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study
Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, Sung Hee Choi, Nam H Cho, Hak Chul Jang
Journal of the Endocrine Society.2021;[Epub]     CrossRef